bromopyruvate has been researched along with glutamine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuezva, JM; Sánchez-Aragó, M | 1 |
| Bernardini, R; Bertocchi, F; Cardaci, S; Ciriolo, MR; Filomeni, G; Mattei, M; Paci, M; Rizza, S; Rotilio, G | 1 |
| Cardaci, S; Ciriolo, MR | 1 |
| Jardim-Messeder, D; Moreira-Pacheco, F | 1 |
4 other study(ies) available for bromopyruvate and glutamine
| Article | Year |
|---|---|
The bioenergetic signature of isogenic colon cancer cells predicts the cell death response to treatment with 3-bromopyruvate, iodoacetate or 5-fluorouracil.
Topics: Adenosine Triphosphate; Blotting, Western; Cell Death; Colonic Neoplasms; Energy Metabolism; Fluorouracil; Glutamine; HCT116 Cells; Humans; Iodoacetates; Pyruvates; Remission Induction; Signal Transduction | 2011 |
Glutamine deprivation enhances antitumor activity of 3-bromopyruvate through the stabilization of monocarboxylate transporter-1.
Topics: Animals; Antineoplastic Agents; Autophagy; Cell Line, Tumor; Electron Transport Complex II; Glutamate-Ammonia Ligase; Glutamine; Humans; Mice; Mitochondria; Monocarboxylic Acid Transporters; Oxidative Stress; Protein Stability; Proteolysis; Pyruvates | 2012 |
Deprive to kill: glutamine closes the gate to anticancer monocarboxylic drugs.
Topics: Antineoplastic Agents; Cell Death; Glutamine; Humans; Models, Biological; Monocarboxylic Acid Transporters; Pyruvates; Symporters | 2012 |
3-Bromopyruvic Acid Inhibits Tricarboxylic Acid Cycle and Glutaminolysis in HepG2 Cells.
Topics: Animals; Citric Acid Cycle; Glutamine; Hep G2 Cells; Humans; Isocitrate Dehydrogenase; Ketoglutaric Acids; Kidney; Liver; Mice; Mitochondria; Oxygen Consumption; Pyruvates; Succinate Dehydrogenase; Sulfhydryl Compounds | 2016 |